Cargando…
Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations
In this paper we present our experience on the treatment at home of Covid+ symptomatic patients. One hundred and eighty-two subjects (111 men and 71 women) aged from 32 to 71 years have been consecutively followed at home in telemedicine from 1(st) September to 24(th) December 2020. We were informed...
Autores principales: | D'Amato, Gennaro, Acanfora, Luca, Delli Paoli, Lucrezia, D'Amato, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844717/ https://www.ncbi.nlm.nih.gov/pubmed/33532070 http://dx.doi.org/10.4081/mrm.2021.748 |
Ejemplares similares
-
Authors’ response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations
por: D'Amato, Gennaro, et al.
Publicado: (2021) -
Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D’Amato et al.
por: Adiletta, Girolamo, et al.
Publicado: (2021) -
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007) -
Effects of climatic changes and urban air pollution on the rising trends of respiratory allergy and asthma
por: D'Amato, Gennaro
Publicado: (2011) -
Climate change and respiratory diseases
por: D’Amato, Gennaro, et al.
Publicado: (2014)